The Role of Ultrasonography-Guided Fine-Needle Aspiration Biopsy in the Management of Nonpalpable and Palpable Thyroid Nodules

Publisher Website
Google Scholar
Abstract
The introduction of highly sensitive imaging techniques has made it possible to detect many nonpalpable thyroid nodules (non-PTN). We investigated the value of ultrasound-guided fine-needle aspiration biopsy (US-guided FNAB) as a diagnostic tool in the management of non-PTN as well as palpable thyroid nodules (PTN) that were considered difficult to aspirate without guidance. US-guided FNAB was performed on a total of 119 nodules (71 palpable and 48 nonpalpable) from 119 patients between 1992 and 1996. All available clinical and follow-up data were reviewed. Surgical follow-up was available in 24 cases. The patients included 100 females and 19 males ranging in age from 9 to 81 years (average, 51 years). FNA diagnoses (PTN versus non-PTN) included papillary carcinoma (12.7% [9/71] versus 4.2% [2/48], follicular neoplasm (16.9% [12/71] versus 0%), medullary carcinoma (1.4% [1/71] versus 0%), atypical cytology (5.6% [4/71] versus 2.1% [1/48], non-neoplastic thyroid (63.4% [45/71] versus 85.4% [41/48]) and unsatisfactory (0% versus 8.3% [4/48]). In 2 cases of occult papillary carcinoma, risk factors included radiation exposure (1 case) and a newly developed nodule during follow-up for hypothyroidism (1 case). Subsequent surgical follow-up (24 cases) confirmed the FNA findings, except for a case of Hürthle cell adenoma and 1 of Hashimoto's thyroiditis diagnosed as papillary carcinoma and follicular neoplasm, respectively. US-guided FNAB in most non-PTN are diagnosed as benign. For most patients with non-PTN and without any high-risk factors, a conservative approach such as clinical follow-up may be a more cost effective and logical approach. In contrast, US-guided FNAB is more useful in diagnosing biologically significant lesions in PTN that may be difficult to aspirate without guidance.